Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

By Palmer Daniel  

Annals of Surgical Oncology, Vol. 15, Iss. 7, 2008-07 ,pp. : 2061-2061

Springer Publishing Company

Access to resources Recommend Favorite

Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancer

By                                          

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-01 ,pp. : 787-792

Spandidos Publications

Access to resources Recommend Favorite

A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin

By Palmer Daniel   Stocken Deborah   Hewitt Helen   Markham Catherine   Hassan A.   Johnson Philip   Buckels John   Bramhall Simon  

Annals of Surgical Oncology, Vol. 14, Iss. 7, 2007-07 ,pp. : 2088-2096

Springer Publishing Company

Access to resources Recommend Favorite

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

By Katz Matthew  

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1794-1801

Springer Publishing Company

Access to resources Recommend Favorite

Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis

By Xu C.   Xue X.   Liang N.   Xu D.   Liu F.   Yu X.   Zhang J.  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 4, 2014-04 ,pp. : 549-559

Springer Publishing Company

Access to resources Recommend Favorite